Tag Archives: GlaxoSmithKline
California Receives Lion’s Share in National Settlement with Drug Maker GlaxoSmithKline
Earlier this month, GlaxoSmithKline, one of the world’s largest pharmaceutical companies, agreed to pay $105 million to settle claims that it illegally promoted off-label uses of the antidepressants Paxil and Wellbutrin and the asthma drug Advair. California will receive over $7 million in the case, which is the largest share of the 44-state settlement…. Read More »
FDA Recalls Dangerous Drugs and Defective Medical Devices by the Dozen Every Month
Over a dozen drugs have been recalled by the U.S. Food and Drug Administration (FDA) in the last 60 days alone. These recalls have struck makers of dietary drugs and supplements as well as some of the largest pharmaceutical companies in the country, including Pfizer, Baxter and GlaxoSmithKline. Some of the reasons for the… Read More »
